Skip to main content

Postdoc Portrait: Vidhyadhar Nandana Targets Biomolecular Condensates in Disease

This postdoctoral researcher investigates biomolecular condensates to uncover novel therapeutic strategies for cancer and neurodegenerative diseases.

Brought to you byThe Scientist
| 1 min read
Headshot of postdoctoral researcher Vidhyadhar Nandana.
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Vidhyadhar Nandana is a postdoctoral researcher at Fox Chase Cancer Center. He conducts biochemical and biophysical characterizations of biomolecular condensates to pioneer novel therapeutic strategies for cancer and neurodegenerative diseases. In this Postdoc Portrait interview, he shares the importance of his work and what he hopes his research will accomplish.

Uncovering Biomolecular Condensates and Proteome Dynamics

Q | What scientific problem are you trying to solve?

Proteins and RNAs form dynamic membrane-less compartments in cells called biomolecular condensates. These condensates organize key biochemical processes inside the cell, and their aberration is increasingly linked to cancer and neurodegenerative diseases. My work involved biochemical and biophysical characterization of condensates and how we can use this knowledge to target condensates in diseased conditions.

Q | What drew you to biochemistry?

I was trying to crystallize protein complexes in my PhD, and they never got crystallized due to their long intrinsically disordered regions. Instead, they form droplets similar to condensates in the cell. I was fascinated by this observation.

Q | What’s one thing you learned from your research that you didn’t expect?

Initially, I thought there were handful of condensates in a cell but at least 40 percent of the human proteome has the propensity to form condensates.

Q | If your research succeeds, what could it change for science or society?

My research will bring novel strategies for targeting condensates in diseased conditions.

Q | What question are you most excited to answer next?

I am excited about applying sonogenetics to modulate condensates in neurodegenerative diseases.

Responses have been edited for length and clarity.

Are you a researcher who would like to be featured in the “Postdoc Portraits” series? Send in your application here.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

​Beckman Coulter
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni

Products

Stellaromics Logo

Stellaromics Expands Pyxa Adoption as Instruments are Installed at Leading Research Institutions Across the U.S. and EuropeStellaromics, Inc., the leader in 3D

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform